The immune system has evolved to survey and respond appropriately to the universe of foreign pathogens, while at the same time deploying an intricate repertoire of mechanisms that keep responses to host tissues in check. For the adaptive immune system, specificity and sensitivity are provided by a large repertoire of antigen T-cell receptors (TCRs) constructed in their extracellular domain to recognize antigenic peptide fragments restricted and presented by histocompatibility complex molecules, and coupled through intracellular domains to signal transduction modules that serve to transmit environmental cues inside the cell. In this review we consider recent evidence that has provided insight into how altered TCR signaling thresholds could contribute to human autoimmune arthritis, including rheumatoid arthritis (RA), and the spondyloarthropathies (SpA). We also discuss mechanistic studies that demonstrate how perturbations of T-cell antigen receptor signaling in the SKG mouse model can promote systemic autoimmunity and the intersection with essential innate immune pathways that lead to the development of chronic inflammatory phenotypes. Keywords: spondyloarthropathy; rheumatoid arthritis; T-cell receptor; innate immunity
The immune system has evolved to survey and respond appropriately to the universe of foreign pathogens, while at the same time deploying an intricate repertoire of mechanisms that keep responses to host tissues in check. Moreover, human populations have evolved with a genome shaped by interaction with infectious organisms. The need for protection against pathogens has driven evolution of the innate and adaptive immune system through selection pressure on a population basis, characterised by a highly polymorphic major histocompatability complex (MHC) combined with genetic variants that control the thresholds for, and the magnitude of immune responses. 1 For the adaptive immune system, specificity and sensitivity are provided by a large repertoire of antigen T-cell receptors (TCRs) constructed in their extracellular domain to recognize antigenic peptide fragments restricted and presented by MHC molecules, and coupled through intracellular domains to signal transduction modules that serve to transmit environmental cues inside the cell. The response to these environmental cues manifests in cellular activation, differentiation and lineage-specific effector or regulatory lymphocyte responses. As this pathway is one of the best defined in the immune system, and has been implicated in immunopathology for many decades, there has been great interest in defining to what extent inherited defects of TCR signaling might translate into immune pathology in general, and autoimmune diseases in particular. In this review we will consider recent evidence that has provided insight into how altered TCR signaling thresholds could contribute to human autoimmune arthritis, including rheumatoid arthritis (RA), and the spondyloarthropathies (SpA). We discuss mechanistic studies that demonstrate how perturbations of T-cell antigen receptor signaling can promote systemic autoimmunity and the pathways that lead to the development of distinct chronic inflammatory phenotypes in particular.
The components that make up the TCR signaling modulesprotein tyrosine kinases, phosphatases and adaptor proteins-are essential for lymphocyte development and function. 2 For example, null mutations of the zeta-chain-associated protein kinase ZAP-70, arising either through inherited mutations or engineered by gene targeting, cripple antigen receptor signals and lead to a profound state of immune deficiency. [3] [4] [5] Early lymphocyte development in the thymus (for T cells) is blocked and, because positive selection is attenuated, a full complement of T lymphocyte specificities in the periphery is absent. Although null mutations of antigen receptor subunits, or their downstream signaling modules, is a rare event in man, it is becoming increasingly apparent that more subtle variants in genes encoding antigen receptor signal transduction pathways may contribute to immune pathology in ways that might not have been predicted. 6 Indeed, as we will discuss, data emerging from mouse models indicate that distinct thresholds of signaling can give rise to specific disease phenotypes, due in part to the fact that the TCR is pleiotropic, delivering quantitatively distinct signals in different cell lineages, including effector and regulatory cells. 7, 8 EVIDENCE FOR ABERRANT TCR SIGNALING THRESHOLDS IN RA For decades it has been reported by many laboratories that T cells from patients with RA are anergic, or hyporesponsive to antigen receptor engagement (reviewed in Thomas et al. 9 ). In the earliest studies, this conclusion was based on depressed DTH responses in vivo and impaired lymphocyte transformation in vitro. 10, 11 This paradox has been difficult to reconcile with the observation of persistently activated T cells in peripheral blood and inflamed synovial joints, and enhanced autologous mixed lymphocyte responses when T cells are stimulated by RA synovial dendritic cells (DCs). 12 On the other hand, this state of impaired antigen responsiveness seems in line with the clinical state of immune suppression characteristic of RA patients with severe, active inflammatory disease. Although it was suggested that this immune state could be due to the effects of immunosuppressive therapy, this view cannot account for the observation that immune responses are often restored in patients following successful treatment, especially with biological therapy. [13] [14] [15] This implicates the inflammatory process in attenuating adaptive immunity. Indeed, suppressive influences on T-cell function may well derive from inflammationdriven upregulation of multiple regulatory pathways in antigen presenting cells, characterized by enhanced expression of interleukin (IL)-10, IL-1 receptor antagonist (IL-1Ra), transforming growth factor-b, indoleamine-2,3-dioxygenase and inducible nitric oxide synthase activity. [16] [17] [18] [19] 
ACQUIRED CHANGES IN TCR RESPONSIVENESS IN RA T CELLS
Insights into the molecular and cellular basis for altered TCR responsiveness have uncovered a panoply of mechanisms for the variable state of T-cell responses. Some studies have demonstrated clear hyporesponsiveness to TCR engagement, while others have demonstrated reduced thresholds of TCR signaling. Some of the more common aberrations of TCR signaling in RA T cells, derived from cellular or biochemical analyses ex vivo of isolated peripheral blood or synovial fluid lymphocyte samples, are summarized in Table 1 .
The peak incidence of RA is in the fifth or sixth decade. 20 Accordingly, it has been proposed that distinct features of the ageing immune system, in the context of genetic variants that might serve to accelerate the ageing process, might contribute to RA pathogenesis. Evidence that the ageing immune system may perturb pathways of T-cell activation is suggested by the expression of terminally differentiated phenotypes, 21 shortened telomeres, 22 and, when comparing aged with young donor T cells, redistribution of phosphoproteins, 23 and impaired recruitment of signaling intermediates into lipid rafts, associated with rigidity of the plasma membrane due to increased cholesterol content. 24 Although reduced TCR signaling should cause self-reactive thymocytes to be positively selected, such a decrease in TCR signaling for thymic deletion might be canceled out by a commensurable decrease in TCR signaling for the activation of T cells in the periphery, so that the whole system readapts to novel but fixed 'calibration set-points' (or 'tuning'). 25 How could reduced TCR signals in peripheral T cells translate to immune pathology? There are several possibilities, none mutually exclusive. For example, reduced TCR signals in regulatory Tcell (Treg) subsets would permit unbridled reactivity of effector T-cell responses. This might become more likely because of enhanced selection in the thymus of Treg cells with intermediate affinity for self antigens in the repertoire. Such FoxP3+ cells have been shown to have high plasticity in the periphery, for example, as provoked by IL1b for conversion to IL-17-expressing autoreactive effector T cells. Activation-induced cell death of effector T cells might also be perturbed. A third possibility is that impaired IL-2 production, as a consequence of reduced TCR signals in recently activated effector T-cell precursors, might lead to a failure of Treg fitness, activationinduced cell death, or both. Although studies of human T cells lag behind those in mice, one recent report has demonstrated an association between low TCR signal strength and increased production of IL-17. 26 Thus, although a wide variety of aberrations of T-cell responsiveness, defined at a cellular or biochemical level, exist in patients with RA, the extent to which these anomalies are the cause or the effect of the chronic inflammatory process is unclear.
DO HUMAN GENETIC STUDIES SUPPORT A FUNDAMENTAL ROLE FOR T-CELL ACTIVATION AND DIFFERENTIATION IN RA?
Analysis of large cohorts of RA patients has demonstrated that there are at least 30 gene loci, confirmed in validation cohorts or identified through meta-analyses, that contribute to disease susceptibility. 27 The MHC remains the locus most strongly associated with RA, especially HLADRB1. The major influence of this association appears to be in the presentation of disease-associated autoantigens. For example, disease-associated HLA-DR4 molecules (HLA-DRB1*0401) present distinct immunodominant epitopes when compared with the closely related disease non-associated HLA-DR4 counterpart (HLA-DRB1*0402). 28 Data from animal models also indicate that there may exist a preference for the binding and presentation of citrullinated peptides by HLA-DR4 and the activation of arthritogenic T cells, 22 These varied roles of the HLA-DR genetic association in RA may not be mutually exclusive. Besides the HLA association, candidate gene approaches and genome-wide association studies have identified an allelic variant in the protein tyrosine phosphatase Lyp, encoded by PTPN22 to be one among those that are strongly associated with RA in patients of Caucasian ancestry. 34, 35 The finding that PTPN22 single-nucleotide polymorphisms are associated with not only RA, but also type 1 diabetes, systemic lupus erythematosus, Hashimoto's thyroiditis and Addision's disease, has generated great interest in the functional consequences of the disease-associated mutant, not least because of the data implicating a role for Lyp as a negative regulator of TCR signaling. 36 Genetic evidence points to the R620W mutant (C1858T) as being the causal variant in RA and type 1 diabetes. Interestingly, however, the association of PTPN22 with Crohn's disease is in the opposite direction. 37 The R620W mutation reduces the interaction between the P1 domain of Lyp and the SH3 domain of an associated kinase Csk. Both proteins are recruited as a complex to the scaffold protein PAG, serving to dephosphorylate the Y394 within the activation loop of the kinase domain of Lck (through the function of the phosphatase Lyp/PEST-domain enriched tyrosine phosphatase (PEP)), while phosphorylating a negative regulatory Tyr (Y505) in the C-terminal tail of Lck (through the function of the kinase Csk; reviewed in Burn et al. 38 ).
The notion that a causal variant in a phosphatase might predispose to autoimmunity through perturbations of TCR signaling is particularly attractive, and is supported by the phenotype of PEP-deficient T cells, which exhibit an activated phenotype. 39 However, the results of the first functional genomic studies in man indicated that R620W was in fact a gain-of-function variant associated with attenuation of TCR signaling, proliferation and TCR-induced IL-2 production. 40 Accordingly, it was proposed that the disease-associated variant might impair thymic-negative selection on the one hand, while perturbing Treg function on the other. Analysis of T cells from genotyped donors lends support to this view. 41, 42 In contrast, co-transfection studies of Lyp together with Csk indicate that the R620W variant is a hypomorph. 43 More recent data indicate that the disease-associated Lyp, and its murine orthologue, may be an unstable loss-of-expression variant, due to increased susceptibility to calpain-and proteosome-mediated degradation. 41 Studies of R619W-expressing murine T cells demonstrated enhanced proliferative responses and TCR-induced phosphorylation of Lck and ZAP-70. Proliferation and TCR-induced pErk expression were also increased in T cells from R620W homozygous mutant human donors. According to these data, the variant is associated with reduced expression of Lyp, and presumably loss-offunction at a cellular level, and a state of T-cell hyperactivity or hyperresponsiveness. In view of these conflicting data, more work is needed to establish how autoimmune disease-associated variants of Lyp perturb TCR signaling thresholds. In addition, several studies in healthy individuals and those with autoimmune disease demonstrate dramatic effects of the R620W variant of PTPN22 on B-cell memory and autoantibody production, which may be just as relevant as its effects on T-cell function. 42, 44 Allelic variants have been reported at the CD28, CTLA4, PRKCQ and CD247 loci, 27,45 all of whose gene products regulate receptor proximal TCR signaling events, including very early events in the immune synapse. 46 The causal variants have yet to be defined and so until there are data describing the function of such variants, at least in RA, it is difficult to predict the impact of altered function in the context of TCR signaling thresholds. On the other hand, genetic polymorphism in CD247, which encodes the TCRz chain invariant subunit (reported to be downregulated in autoimmune disease), has been studied in more depth in SLE, where disease-associated 3¢UTR variants are thought to be loss-of-expression mutants, manifest in peripheral blood T cells as increased numbers of T cells expressing low levels of TCRz protein. 47 When taken together, these data support the view that allelic variants associated with RA induce rather subtle perturbations in pathways of T-cell activation to either alter signal input (regulated by MHC class II, the molecular modifications of antigenic peptide and expression of the TCR/CD3 complex), signal transmission (PTPN22, CD28, CTLA4, PRKCQ) or events downstream (signal output) arising through variation in the function or expression of STAT4, REL or IL-2/IL-2R ( Figure 1 ).
WHAT HAS THE SKG MOUSE TAUGHT US ABOUT THE PATHOGENESIS OF AUTOIMMUNE ARTHRITIS?
A spontaneous mutation in a colony of BALB/c-the SKG mutantwas noted to be associated with the development of inflammatory autoimmune arthritis. The key features of this model are that (1) a genetic defect in ZAP-70, a protein tyrosine kinase expressed by T cells, is necessary and sufficient to cause T-cell-mediated autoimmune arthritis, and (2) these clinical manifestations require environmental T-cell receptor signaling S Sakaguchi et al stimuli.
In the following sections, we described how a point mutation that perturbs TCR-proximal signaling leads to enhanced thymic production of pathogenic self-reactive (including arthritogenic) T cells, and of the Foxp3-expressing natural Treg cells that should normally keep them in check. We will then go on to describe peripheral activation, proliferation and effector T-cell differentiation leading to autoimmune arthritis, and the impact of environmental factors on these processes.
PATHWAYS TO THE GENERATION OF ARTHRITOGENIC T CELLS AND ALTERED NATURAL TREG CELL FUNCTION IN SKG MICE
In SKG mice, mutant ZAP-70, which attenuates TCR signaling, affects the TCR repertoire of developing T cells. Because of this signaling defect, only highly self-reactive T cells with strong TCR-proximal signaling that compensate for the mutation are positively selected. The same signaling defect attenuates strong self-peptide MHC ligandinduced TCR signals that would otherwise induce apoptosis, and so negative selection is also impaired. 7, 48 These anomalies in the thymus skew the whole T-cell repertoire to become a highly self-reactive one, allowing arthritogenic clones to reach the periphery. The change in TCR repertoire depends on the degree to which the TCR signal is attenuated. Thus, skg/null mice, generated by mating homozygous SKG mutant mice with ZAP-70-deficient mice, develop more severe arthritis than SKG mice. In contrast, skg/+ mice (skg heterozygous) do not develop arthritis, even though their T cells are skewed to a selfreactive repertoire to an extent greater than wild-type mice. With their relative peripheral T-cell deficiency resulting from reduced positive selection, SKG T cells exhibit more robust proliferative responses than wild-type control T cells, through strong recognition of self-pMHCs expressed in vivo. 49 Consistent with this is the finding that in vitro autologous mixed lymphocyte reactions, in which CD4 + T cells proliferate by recognizing self-pMHC presented by autologous DCs, CD4 + T-cell proliferation was more vigorous if derived from SKG than from wild-type mice. In contrast, SKG T cells were much less responsive than wild type CD4 + T cells in allogeneic MLR. 49 Thus, the SKG thymus is abnormal, as it generates T cells with a variety of anti-self specificities. This indicates that the signal intensity emanating from autoreactive TCRs is sufficient to promote proliferation in spite of the attenuated skg ZAP-70 TCR signal, which conveys hyporesponsiveness to non-self-antigens, such as alloantigen. The skewing in the TCR repertoire in SKG mice promotes positive selection and attenuates negative selection of autoreactive arthritogenic T cells; other self-reactive T cells, which would be normally be positively selected in wild-type animals, fail to be selected. 48 This genetically alters the susceptibility of the background strain to particular autoimmune diseases, such that mice bearing the skg ZAP-70 mutation are more susceptible to some autoimmune diseases but more resistant to others. For example, depletion of Treg cells in BALB/ c mice promotes autoimmune gastritis but very rarely autoimmune arthritis. Depletion of Treg cells in SKG mice, on the other hand, increases incidence of arthritis but reduces incidence of gastritis when compared with BALB/c controls. Similarly, diabetes prone non-obese diabetic mice are less susceptible to type 1 diabetes but more susceptible to arthritis by introducing the skg mutation. These changes to autoimmune disease susceptibility exhibit a gene dosage effect, such that skg heterozygous mice develop each autoimmune disease with intermediate incidence. Thus, the genetically determined SKG-induced TCR signaling impairment alters susceptibility to multiple autoimmune diseases by altering the self-reactive T-cell TCR repertoire. Furthermore, the more severe the TCR signaling defect and hence acquisition of a self-reactive TCR repertoire, the greater the likelihood of systemic autoimmune diseases such as arthritis, and the lower the likelihood of organ-specific diseases such as diabetes and autoimmune gastritis.
The skg ZAP-70 mutation influences the Foxp3 + natural Treg cell TCR repertoire and function. 48 In wild-type animals, the TCRs of FoxP3+ Treg cells select thymic self-pMHC ligands with higher affinity than for conventional T-cell TCRs. The skg ZAP-70 mutation skews the Treg cell TCR repertoire towards even higher self-reactivity than the repertoire of conventional T cells, which are already more selfreactive than normal in SKG mice. As discussed above, Foxp3 + Tregs require both TCR and IL-2 signals for suppressive functions, and thus impaired TCR signaling results in impaired suppressive function in vivo and in vitro in SKG ZAP-70 mutant mice. 50 For example, in cotransfer experiments, Foxp3 + CD25 + CD4 + Treg cells from nonarthritic SKG mice were less capable of suppressing arthritis development than equal numbers of Foxp3 + CD25 + CD4 + Treg cells from BALB/c mice. 48 The degree of impairment of suppressive function depends on the severity of signal reduction, such that Foxp3 + Treg cells from skg/ À mice are more self-skewed and much less suppressive in vitro than skg/skg Treg cells. 48 Thus, given that both potentially self-reactive T cells and naturally occurring Foxp3 + CD25 + CD4 + Treg cells undergo the same selection process in the thymus, the skg ZAP-70 anomaly alters the TCR repertoire of both the populations, leading to predominant development of arthritogenic self-reactive T cells and natural Treg cells with a similar self-reactivity, but impaired suppressive function. Put into context, the effects of altered TCR signaling thresholds in ZAP-70 mutant SKG mice on central and peripheral T-cell tolerance can be viewed as one point on a spectrum of TCR signal strengths. 48 It is difficult to determine exactly where the SKG mutant mice sit on this spectrum, but when the SKG mutation is compared with the effects of the mrd and mrt ZAP-70 kinase mutants, generated by mutagenesis in the Goodnow laboratory, one can begin to understand the complexity of TCR signaling and its impact on different cell lineages. 8 This is illustrated in Figure 2 , where graded signaling defects generated by homozygous crosses (mrd/mrd and mrt/mrt) and compound homozygous mutations (mrd/mrt) are shown to induce quite distinct phenotypes, genetic background aside. Importantly, each genetic variant impacts on immune competence as well as promoting immune pathology. The subtleties of graded TCR signaling defects are further illustrated by the work of Weiss and colleagues who generated YYAA knock-in mice carrying engineered mutations of tyrosine residues Y315 and Y319 to alanine in the domain of ZAP-70 that serves to provide scaffolding function. Although these mice have anomalies of thymic selection and reduced numbers of thymic Treg similar to SKG mice and develop autoimmunity, as demonstrated by rheumatoid factor autoantibodies, they do not develop autoimmune arthritis. 51 It was suggested that differences in TCR repertoire could account for the distinct phenotypes observed.
SPONTANEOUS DIFFERENTIATION OF ARTHRITOGENIC EFFECTOR T CELLS IN SKG MICE
A repertoire of arthritogenic T cells in the periphery of SKG mice is not sufficient for the clinical expression of inflammatory arthritis, 52 because they need to be activated and differentiate into arthritogenic effector T cells. It turns out that IL-17-secreting Th17 cells are the major effector T cells in SKG arthritis. 49, 53 Although both Th17 and Th1 cells are abundant in arthritic but not in unaffected joints in SKG mice, it is the IL-17-deficient SKG CD4 + T cells that are unable to transfer disease to syngeneic T-cell-deficient recipients. IL-6, which promotes Th17 differentiation in mice, is required for disease development, as arthritis did not develop in IL-6-deficient mice, 54 and transfer of IL-6 À/À SKG CD4 + T cells to IL-6 À/À immunodeficient RAG À/À mice failed to induce either Th17 cells or arthritis. In contrast, Th17 differentiation was intact in control IL-6 +/+ RAG À/À -recipient mice to which IL-6 +/+ SKG CD4 + T cells were transferred; arthritis occurred with all recipients. On the other hand, interferon (IFN)-g deficiency enhanced arthritis-in part by facilitating Th17 differentiation. Arthritis developed spontaneously in IFN-g-deficient SKG mice even in an SPF environment. 49 Thus, IL-6 facilitates whereas IFN-g inhibits the differentiation of arthritogenic T cells to Th17.
In autologous mixed lymphocyte reactions with SKG T cells as responders, IL-6 was predominantly DC derived, while tumor necrosis factor (TNF) was produced by CD4 + T cells/thymocytes and DCs, and IL-17 was produced by CD4 + T cells but not by CD4SP thymocytes. 49 Cytokine production in vitro was blocked with anti-CD40L monoclonal antibody and to a lesser extent by anti-OX-40L. These in vitro data imply that, in SKG mice, thymic-derived self-reactive T cells are activated in the periphery in response to strong recognition of selfpMHC complexes, and thus stimulate upregulation of CD80/CD86 by APCs in a CD40/CD40L-dependent interaction, and that this feeds forward on T-cell proliferation. The pathway of Th17 differentiation is further enhanced, at least in vitro, by APC derived IL-6, TNF, IL-1b and IL-23, and tissue stroma-derived transforming growth factor-b. 49 Th17 cells migrate to the joints in a chemokine-dependent manner, driven, at least in part through expression of the chemokine receptor CCR6. 49 Moreover, synovial fibroblasts from arthritic joints of both SKG mice and RA patients express the CCR6 ligand, CCL20, in abundance. CCL20 expression is increased in vitro by IL-1b, IL-17 or TNF, and suppressed by IFN-g or IL-4. 49 Consistent with the dependence of SKG arthritis on Th17, anti-CCR6 blocking monoclonal antibody significantly inhibited arthritis development in SKG mice.
Owing to their high self-reactivity, SKG T cells differentiate into Th17 cells as a result of efficient cross-talk with APCs. This creates a positive-feedback loop: SKG T cells promote a cytokine milieu for their own differentiation to Th17. Furthermore, CCR6/CCL20-driven homing of Th17 cells to the joints is crucial for the development of Th17 cell-mediated autoimmune arthritis in SKG mice; it could be assumed that similar pathways may promote disease in patients with RA. It is still unclear why this chemokine/chemokine receptor profile is linked to specific synovial joint homing.
PROVOCATION OF CLINICALLY OVERT ARTHRITIS BY ENVIRONMENTAL AGENTS
Despite spontaneous differentiation of Th17 with arthritogenic antigen specificities, SKG mice houses under SPF conditions and do not suffer from arthritis, while severe arthritis occurs at high incidence under microbially conventional conditions. 53 Interestingly, when SKG mice born in an SPF environment are transferred to conventional conditions after weaning, their disease incidence is equal to that of mice born in conventional conditions, suggesting that environmental factors trigger disease. However, injection of several microbial-derived substances dose-dependently evoked arthritis in SKG mice under SPF conditions, 49, 52, 53 including zymosan (a crude yeast cell wall extract), b-glucans (glucose polymer b-1, 3-D-glucans) and mannan (poly-mannose). Polyinosinic-polycytidylic acid (Poly (I:C)), a double-stranded RNA construct with molecular features of some viruses, was mildly arthritogenic when injected every other day for 4 months. 52 The most plausible mechanism by which these diverse microbial substances trigger autoimmune arthritis in SPF SKG mice is through activation of self-reactive T cells as a result of innate immune stimulation, rather than a direct arthritogenic effect. These direct effects are usually transient, mild, non-T-cell-mediated and absent after mannan injection. 49, 52, 53 Innate responses include DC maturation in response to zymosan through toll-like receptor 2 and 6. As a result, DCs upregulate expression of costimulatory molecules CD80/ CD86, CD40, and class II MHC, and secrete a wide range of proinflammatory cytokines including IL-1, IL-6, IL-12, IL-23 and TNF. 
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Beta-glucans, the main constituent of zymosan, similarly stimulate DCs through the Dectin-1 receptor. Laminarin or curdlan, (linear or branching forms of b-glucan respectively) both induce SKG arthritis, and inhibition of Dectin-1 signaling prevents disease development. However, zymosan also activates the alternative pathway of complement (C). The b-glucan structure can also be recognized by ficolin-L, a key receptor of the lectin pathway of C-activation. Thus, substances containing b-glucan also contribute to triggering SKG autoimmune disease through complement activation. In this regard, injection of mannan, a potent activator of the lectin pathway of C activation, also induced arthritis in SKG mice when housed under SPF conditions. 53 Furthermore, C5a, a key anaphylotoxin of the complement pathway and a product of lectin, classical and alternative pathways, stimulated macrophages but not DCs, to produce inflammatory cytokines in synergy with toll-like receptor signaling, including IL-6. In vivo, C5a receptor (C5aR)-deficient SKG mice prevented differentiation and expansion of Th17 cells in spite of mannan or b-glucan stimulation, leading to attenuation of the development of arthritis. 53 Collectively, these findings indicate that a broad spectrum of microbes, including fungi, bacteria and viruses, are involved in the initiation chronic autoimmune arthritis in SKG mice through their capacity to stimulate innate immunity in various ways, for example, stimulation of DCs and macrophages through toll-like receptor, Dectin-1 and C activation. Taken together, studies of autoimmune pathogenesis in SKG mice indicate that, in hosts bearing the specific SKG genetic alteration and autoimmune predisposition, a variety of environmental agents, rather than a specific etiological one, triggers a particular form of autoimmune inflammatory arthritis. Of importance, the degree to which such environmental factors are required to trigger disease depends on the magnitude of the genetic defect, as illustrated by the development of arthritis in skg/ À mice in the absence of stimulation of innate immunity in SPF conditions. The model suggests the hypothesis that a one-time 'hit-and-run' exposure to environmental microbial agents may be sufficient to trigger chronic arthritis in individuals with an arthritogenic autoimmune T-cell repertoire as a consequence of genetic predisposition.
SPONDYLOARTHROPATHY: INFLAMMATORY ARTHRITIS DISTINCT FROM RA
SpA are common arthritic inflammatory diseases, affecting 1-3% of the population. 55 They consist of several rheumatic conditions including ankylosing spondylitis, reactive arthritis, psoriatic arthritis and arthropathy of inflammatory bowel disease (IBD). They have been previously grouped together on the basis of their shared distinctive clinical features and genetic susceptibility. Recent advances suggest that the IL-17 group of cytokines may be critical for the pathogenesis of SpA.
The distinctive clinical features of SpA are axial involvement, including inter-vertebral discs and sacro-iliac joints, and enthesitis (inflammation at sites of ligament and tendon insertions) together with certain extra-articular manifestations ( Table 2) . Although all the the entire SpA group shares common clinical features, each condition has a distinct set of symptoms. Notably ankylosing spondylitis presents with typical symptoms of inflammatory back pain in a young person, with males three times more common than females, which may be complicated by enthesitis (for example, plantar fasciitis or Achilles tendonitis), uveitis, IBD or psoriasis. On the other hand, reactive arthritis is characterized by inflammatory spinal pain and/or peripheral arthritis within 6 weeks of specific infections, including bacterial gastroenteritis and genitourinary infections: organisms include Shigella, Yersinia and Chlamydia. Enthesitis is common and dactylitis (diffuse swelling of a digit) may occur. Patients may also develop mucocutaneous ulcers, conjunctivitis and occasionally uveitis. Patients with psoriatic arthritis have a current, past or family history of psoriasis and peripheral inflammatory arthritis, with or without inflammatory back pain. Patients with arthropathy of IBD (enteropathic arthritis) have IBD and peripheral inflammatory arthritis, with or without inflammatory back pain. CLUES TO SpA AND RA PATHOGENESIS FROM THEIR RESPONSE TO TREATMENT Biologic agents that inhibit TNF, IL-6, B7-CD28 and B cells are all effective therapies for RA. Inhibitors of TNF have dramatically improved the quality of life of patients with SpA (ankylosing spondylitis, psoriatic arthritis and IBD). They are clinically effective for both peripheral and axial arthritis, and for extra-articular manifestations but do not affect the progression of ankylosis. In early clinical trials, inhibitors of B7-CD28 and IL-23 appear to improve psoriatic arthritis 56, 57 and anti-IL-23 improved Crohn's disease. 58 Inhibition of IL-17 convincingly improved psoriasis and AS (although reported only in abstract form so far), but had modest effects in RA. 59, 60 Anti-IL-23 has not been trialed in RA.
PATHOGENESIS OF SpA: HUMAN STUDIES
Early ideas about the pathogenesis of inflammatory arthritis, including RA and SpA, revolved around aberrant or dominant Th1 responses. 61 However, contradictory evidence emerged with several studies in animal models of autoimmune arthritis. A lack of protection or accelerated autoimmune arthritis in IFNg-deficient mice, suggested a protective or beneficial role for IFNg. 62, 63 Both IL-4 and IFNg-secreting T cells were demonstrated in human SpA lesions. 64 However, SpA patients were less able to generate IFNg-producing T cells than controls. 65 The discovery of Th17 cells provided new insight into the contribution of T cells in SpA. A series of studies showed that experimental allergic encephalomyelitis or collagen-induced arthritis developed in mice deficient in IL-12p35 but not IL-23p19 or IL-12p40, 66, 67 suggesting that IL-23 and not IL-12 was critical for the development of these autoimmune diseases. Complementing the relative lack of IFNg-producing T cells in SpA, monocyte-derived macrophages generated from ankylosing spondylitis patients also demonstrated a defect in IFNg production and signaling. 68 However, it is unclear whether this is cause or effect in disease pathogenesis. Recent genetic studies demonstrated that genetic variants in IL23R, IL12B, STAT3 and Card9 are associated with ankylosing spondylitis, psoriasis and IBD (especially Crohn's disease), but not RA. 69, 70 Of interest, not only is there considerable evidence of association of shared genetic polymorphism in multiple clinical forms of SpA, but experimental evidence from human diseased tissues and animal models is emerging that demonstrates common pathogenetic elements across SpA, including psoriasis and AS. One of the common denominators appears to be an IL-17 response following activation of the dectin-1-syk pathway. 71 IL-17 immunity towards micro-organisms, including commensal gut microflora, as well as pathogens such as Chlamydia species, is thought to be integral to the pathogenesis of the SpA diseases, which have long been proposed to be triggered by an abnormal immune response to infection. The heritability of ankylosing spondylitis in twins of 490% suggests that the disease trigger is ubiquitous-likely a micro-organism or set of organisms that triggers a common pathogenetic pathway, rendered more potent by associated polymorphic genes in distinct pathways. 72 Dectin-1 is a receptor for fungal and bacterial b-glucan in innate immune cells and APCs, including neutrophils, monocytes, DCs and gd T cells. Dectin-1 signaling promotes expression of IL-1b, IL-12p35, IL-12p40 and IL-23p19. 73, 74 IL-23 is required for the expansion of IL-17 + cells, and signaling through IL-23R activates Jak2 and STAT3 in T cells. 75, 76 Chlamydia, a triggering genitourinary micro-organism associated with reactive arthritis, promotes expression of IL-23 by APCs through activation of the transcription factor C/EBP homologous protein. 77 Psoriasis is associated with staphylococcal colonization of the skin and streptococcal throat infections. 78 Staphylococcal and streptococcal superantigens have been implicated in T-cell activation and skin homing. 79 Recent studies demonstrate that innate immune cells have a critical role in the IL-23 and IL-17 pathway in SpA.
Neutrophils and mast cells were shown to be the predominant cell types expressing IL-17 in psoriatic skin, and to release IL-17 in the process of neutrophil DNA-anti-microbial extracellular trap formation, which was promoted by IL-23 and IL-1b. 80 Of interest, the frequency of IL-17-secreting cells in spinal facet joints was significantly higher in ankylosing spondylitis patients than in control osteoarthritis patients, and the majority of the IL-17+ cells were neutrophils, with a smaller proportion of mast cells, and very few T cells. 81 In synovial tissue of patients with undifferentiated SpA, the majority of the IL-17+ cells were mast cells and neutrophils. 82 Synovial neutrophil recruitment followed by deactivation has also been noted in the setting of reactive arthritis, following gastroenterological and genitourinary infections, suggesting an important local neutrophil effector role. 83, 84 In ankylosing spondylitis, peripheral blood gd T cells were the major IL-23R+ population, and relative to healthy controls, preferentially expressed IL-17 over IFN-g upon mitogenic stimulation. 85 In contrast, although innate immune cells expressing IL-17 are abundant at diseased tissue sites in SpA, CD4 + Th17 cells have been more difficult to demonstrate. Although some papers found higher frequencies of Th17 cells in peripheral blood of ankylosing spondylitis patients relative to healthy controls, 86, 87 Th17 cell frequencies were very low, and no differences were found in serum or intestinal IL-17 levels. 88, 89 Taken together there is evidence for an IFN-g defect in SpA and for enhanced signaling through dectin-1-associated Card-9 and then of IL-23 through IL-23R, 90 with overexpression of IL-17. However, the weight of evidence suggests that this IL-17 overexpression occurs in innate immune cells, which vary between disease subtypes within the SpA family. Given the critical role of Th17 in infection control, it remains unclear whether innate cells secreting IL-17 are similarly effective in the control of organisms such as fungi colonizing epithelial and mucosal surfaces. 91 
PATHOGENESIS OF SpA: MOUSE MODELS
There are few good animal models of SpA that reproduce human spondylitis, anterior uveitis, Crohn's disease and/or psoriasis. However, considerable progress has been made in psoriasis using human psoriatic skin explants grafted onto SCID mice. 92 HLA-B27/human bmicroglobulin transgenic rats develop a CD4 + T-cell-dependent multiorgan inflammatory disease with the clinical manifestations of peripheral arthritis, spondylitis, psoriasis-like skin lesions, epididymo-orchitis and colitis. 93 The IL-23/IL-17 axis has been shown to be strongly activated in the colon of B27 transgenic rats with SpA-like disease, and this is postulated to result from HLA-B27 misfolding and activation of the unfolded protein response, inducing IL-23. 94 The exact relationship of this finding to human HLA-B27-associated SpA is unclear, as the transgenic rats express a very high B27 copy number (disease severity is correlated with copy number), which might particularly favor the unfolded protein response and endoplasmic reticulum (ER) stress in these rats. In humans, HLA-B27 dimerizes in the ER that can provoke misfolding. However, ERAP1 is genetically associated with both ankylosing spondylitis and psoriasis. These associations are significant only when co-expressed with HLA-B27 and the psoriatic HLA-C risk allele, respectively. 95, 96 As the disease-protective ERAP1 encodes a lossof-function enzyme that trims peptides in the ER as they are loaded onto class I molecules, this implies that the functional HLA-B27 and HLA-C associations involve presentation of MHC class I-restricted peptides, 97 although it is possible that the unfolded protein response is involved.
Several interesting models highlight the critical role of innate immunity in the pathogenesis of SpA. Mice deficient in the DC-specific inhibitory c-type lectin receptor, DCIR, develop enthesitis, ankylosing ankle arthritis and sialadenitis, associated with DC expansion in lymphoid organs. 98 TNFDARE mice overexpress TNF, and spontaneously develop SpA, including peripheral arthritis, spondylitis, enthesitis and Crohns-like ileitis. 99, 100 In this model, arthritis is T-and B-cell independent, whereas IBD was abrogated on a RAGdeficient background, and non-hemopoietic cells expressing TNFreceptor I are sufficient for development of the pathology. 99, 100 Recently, mice deficient in the ubiquitin-editing molecule A20 in DCs were shown to develop spontaneous CD4 + T-cell-dependent colonic IBD and seronegative ankylosing arthritis and enthesitis associated with marked DC activation and myeloid hyperplasia. 101 The themes emerging from these models are the critical balance of innate immune activators and regulators, and the different pathogenetic mechanisms that contribute to clinical expression within the spectrum of human SpA.
INNATE IMMUNE ACTIVATION MEETS ABERRANT TCR SIGNALING IN SpA THROUGH THE SKG MODEL
As fungal b-glucan triggers dectin-1, and this receptor is upstream of the gene cascade associated with human SpA, the Thomas group investigated whether curdlan-treated SKG mice develop clinical evidence of SpA. One week after intraperitoneal curdlan injection, all SKG mice developed enthesitis, ankle and sacro-iliac arthritis, plantar fasciitis and spondylitis. Two months later, mice developed transmural ileitis resembling Crohn's disease and unilateral anterior uveitis. 102 Interestingly, CD4 + T cells from SKG but not BALB/c mice transferred enthesitis/arthritis and spondylitis but not ileitis to SCID-recipient mice. Moreover, the nature of the trigger affected disease severity and clinical expression. Whereas curdlan triggered a rapid onset of arthritis, spondylitis and ileitis, which was more severe in females, mannan triggered mild arthritis and spondylitis, which was equivalent in males and females, but not ileitis. Thus, exposure of the innate immune system to systemic microbial components triggers inflammatory arthritis and spondylitis, when combined with the skg ZAP70 mutation reducing TCR signaling. The nature of the innate signals and microbial environment in which animals are housed, as well as the severity of the genetic lesion strongly affects disease severity, extraarticular organ involvement and gender bias.
Paradoxically, whereas RA is now known to be associated with genetic and functional alterations in TCR signaling, human SpA have not been associated with similar genes provoking deficient signaling of the TCR. On the other hand, the genetic associations with SpA strongly implicate signaling downstream of dectin-1 and IL-23R. However, in spite of a large increase in the number of genetic associations confirmed in ankylosing spondylitis over the past 5 years, only 25% of ankylosing spondylitis heritability has so far been explained. The situation is similar for other members of the SpA family, including psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis, and indeed also for RA. As technology improves and decreases in cost, further genetic associations with SpA are emerging, including RUNX3, which may affect thymic selection and Treg function, and LTBR-TNFRSF1A, which may affect lymphoid organ development and innate immune responses. 103, 104 What does emerge from studies in SKG mice is a reinforcement of current concepts of pathogenesis of human SpA, that is: innate triggers and the microbial microenvironment of the host (including gut, skin and genito-urinary tract) interact with multiple genetic lesions-some protective and others predisposing-to influence disease onset, severity, extra-articular organ involvement and gender bias. Perhaps the most provocative aspect of the development of SpA-like disease in SKG mice is the development of multiple autoantibodies, including autoantibodies directed against cartilage, which are not a feature of human ankylosing spondylitis, and the dependence of arthritis and spondylitis on CD4 + T cells. There is some scepticism as to the involvement of CD4 + T-cell autoimmunity in human SpA, due to the paucity of joint-specific autoantibodies, the demonstration of strong innate responses, the lack of Th17 cells in blood or diseased tissues of SpA patients, and evidence from the TNFDARE mouse model. Interestingly the arthritis in these transgenic mice remained clinically and histologically identical when crossed to a RAG-deficient background, but was more severe when NKT cells were deficient. 99, 105 The observations emerging from several animal models, including SKG mice, demonstrate that multiple mechanisms can contribute to models with features of multisystem SpA, and that innate regulatory populations have a very important role in maintaining tolerance ( Figure 3 ). Different mechanisms may underlie arthritis and IBD in SKG mice treated with curdlan. The genetics of human SpA strongly implicate multiple pathways in different patients depending on genetic background and environmental exposure. Furthermore, more than one abnormal signal is likely to be required to overcome normal innate and adaptive immune regulation.
CONCLUDING REMARKS
Despite some similarities in clinical features (peripheral inflammatory arthritis) and in treatment response, it is striking that almost no genetic associations are shared between RA and SpA, with the exception of a modest association of IL23R and RA. Indeed, in some cases where the same gene is associated, for example, NFKB1 (encoding the p50 subunit of NF-kB) or MHC (RA and ankylosing spondylitis), CD40 (RA and Crohn's) and PTPN22 (RA and Crohn's), the associations have been found to have opposite effects. 106, 107 This suggests that genetic associations with RA and SpA affect tuning around critical adaptive (for RA) and innate (for SpA) immune pathways, either leading to amplification or subtle modifications of the response to inflammatory or infectious triggers, such as smoking, resident oral, respiratory or gastrointestinal microflora and infection. Depending on the genetic variants and the environmental cues, these aberrations manifest as distinct clinical phenotypes associated with common end-organ tissue destruction in the musculoskeletal system. Given the striking propensity of the autoreactive SKG T cells for joints, there is a wealth of insight into RA and SpA pathogenesis yet to be obtained from further elucidation of the interaction of environmental and infectious influences in SKG mice.
